8VY4
Engineering a Tumor-Selective Prodrug T Cell Engager Bispecific Antibody for Safer Immunotherapy
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 31-ID |
Synchrotron site | APS |
Beamline | 31-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2018-06-27 |
Detector | RAYONIX MX225-HS |
Wavelength(s) | 0.9793 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 48.733, 72.725, 126.695 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 34.950 - 1.700 |
R-factor | 0.1814 |
Rwork | 0.179 |
R-free | 0.22760 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.006 |
RMSD bond angle | 0.847 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX (1.21rc1_5049) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 36.400 | 1.790 |
High resolution limit [Å] | 1.700 | 1.700 |
Rmerge | 0.132 | 0.637 |
Number of reflections | 50296 | 7290 |
<I/σ(I)> | 13.2 | |
Completeness [%] | 99.9 | 99.9 |
Redundancy | 7.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 294 | 100 mM Bis-Tris pH 6.5 and 20% Polyethylene glycol monomethyl ether 5000 |